David Allsop
Impact in
- Physiology top 0.1%
- Alzheimer's disease research and treatments
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Physiology 105
- Alzheimer's disease research and treatments 105
- Neurology 33
- Parkinson's Disease Mechanisms and Treatments 26
- Neurological disorders and treatments 10
- Co-authors
- John Hardy (5 shared papers)Omar M. A. El‐Agnaf (22 shared papers)Brian J. Tabner (18 shared papers)David M. A. Mann (16 shared papers)Katerina E. Paleologou (8 shared papers)Penelope G. Foulds (11 shared papers)Nigel J. Fullwood (15 shared papers)Stuart Turnbull (13 shared papers)
- Journals
- Biochemical Society Transactions (10 papers)The FASEB Journal (5 papers)Scientific Reports (5 papers)Neurobiology of Aging (5 papers)Acta Neuropathologica (5 papers)
- Partner nations
- United KingdomJapanUnited States
In The Last Decade
David Allsop
158 papers receiving 12.6k citations
David Allsop's Hit Papers
Peers
Comparison fields: 5 of 180
- Physiology 6.8k
- Neurology 3.5k
- Neurology 1.6k
- Biological Psychiatry 330
- Pharmacology 1.7k
Countries citing papers authored by David Allsop
This map shows the geographic impact of David Allsop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Allsop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Allsop more than expected).
Fields of papers citing papers by David Allsop
This network shows the impact of papers produced by David Allsop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Allsop. The network helps show where David Allsop may publish in the future.
Co-authors
The 25 scholars most cited alongside David Allsop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Amyloid deposition as the central event in the aetiology of Alzheimer's disease Hit paper breakdown → | 1991 | 2054 |
| 2 | Magnetite pollution nanoparticles in the human brain Hit paper breakdown → | 2016 | 833 |
| 3 | Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease Hit paper breakdown → | 2006 | 621 |
| 4 | 1997 | 616 | |
| 5 | 2003 | 499 | |
| 6 | 1990 | 409 | |
| 7 | 2006 | 368 | |
| 8 | 1994 | 270 | |
| 9 | 2002 | 227 | |
| 10 | 2010 | 223 | |
| 11 | 2010 | 217 | |
| 12 | 2005 | 217 | |
| 13 | 2017 | 203 | |
| 14 | 2008 | 197 | |
| 15 | 2008 | 180 | |
| 16 | 2011 | 171 | |
| 17 | 2001 | 171 | |
| 18 | 2004 | 164 | |
| 19 | 2018 | 164 | |
| 20 | 2013 | 153 |
About David Allsop
David Allsop is a scholar working on Physiology, Neurology, Pharmacology, Neurology and Molecular Biology, having authored 160 papers that have together received 13.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (105 papers), Parkinson's Disease Mechanisms and Treatments (26 papers), Prion Diseases and Protein Misfolding (24 papers), Cholinesterase and Neurodegenerative Diseases (17 papers), Computational Drug Discovery Methods (13 papers), Dementia and Cognitive Impairment Research (10 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Neurological disorders and treatments (10 papers). The work is most often cited by research in Physiology (6.8k citations), Neurology (3.5k citations), Neurology (1.6k citations), Biological Psychiatry (330 citations) and Pharmacology (1.7k citations). David Allsop has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include John Hardy, Omar M. A. El‐Agnaf, Brian J. Tabner, David M. A. Mann, Katerina E. Paleologou, Penelope G. Foulds, Nigel J. Fullwood, Stuart Turnbull, Shu‐ichi Ikeda and G.W. Roberts. Their work appears in journals such as Biochemical Society Transactions, The FASEB Journal, Scientific Reports, Neurobiology of Aging and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.